Leadership Team

Dr Elodie Belnoue

Senior Director - Translational Research

Dr Elodie Belnoue

Elodie Belnoue joined AMAL in 2014 and is now Senior Director - Translational Research.

Elodie has been working in the vaccine field for over 17 years and has a strong background in applied vaccinology and immunology. After several years working on malaria immunity, she moved into neonatal vaccinology at the World Health Organization Collaborating Centre for vaccinology in Geneva. During her 10 years at the WHO Centre, Elodie studied neonatal T-cell immunity elicited by new recombinant vectors/adjuvant formulations or during viral infection and she was involved in preclinical studies of new vaccine adjuvants in collaboration with pharmaceutical companies (Sanofi, Statens Serum Institute). She was also managing projects characterising survival niches for bone marrow plasma cells and factors limiting neonatal antibody responses.

Elodie holds a PhD in Immunology from the University of Paris V, France.

back to Leadership Team

You are now leaving our website

Using this link will let you leave a website of Amal Therapeutics or to a different domain under the control of Amal Therapeutics. In the event that the linked site is not under the control of Amal Therapeutics but under the control of a third party or an affiliate in the Boehringer Ingelheim group of companies, Amal Therapeutics shall not be responsible for the contents, processing of personal data of any linked site or any link contained in a linked site, or any changes or updates to such sites.

This link is provided to you only as a convenience, and the inclusion of any link does not imply endorsement by Amal Therapeutics of the site.

Target URL: